DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Wiviott SD, Raz I, Bonaca MP. DECLARE–TIMI 58 Investigators. et al.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med 2019;
380 (04) 347-357
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.